9-valent, quadrivalent HPV vaccines have comparable safety
The 9-valent human papillomavirus vaccine was well tolerated in 16-26 year olds and had a safety profile comparable to that of the quadrivalent vaccine, according to an analysis of seven phase III...
Source: Pediatric News - Category: Journals (General) Source Type: news
More News: Cervical Cancer Vaccine | Gardasil | General Medicine | Genital Warts | Human Papillomavirus (HPV) | Pediatrics | Vaccines